Akita H, Mukai Y, Kubo M, Wada H, et al. Reply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer". Surgery 2024 Dec 20:108952. doi: 10.1016/j.surg.2024.
PMID: 39709286